Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global IV Fluid Transfer Drugs Devices Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global IV Fluid Transfer Drugs Devices Market Status and Forecast (2016-2027)
      • 1.3.2 Global IV Fluid Transfer Drugs Devices Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global IV Fluid Transfer Drugs Devices Supply by Company

    • 2.1 Global IV Fluid Transfer Drugs Devices Sales Volume by Company
    • 2.2 Global IV Fluid Transfer Drugs Devices Sales Value by Company
    • 2.3 Global IV Fluid Transfer Drugs Devices Price by Company
    • 2.4 IV Fluid Transfer Drugs Devices Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional IV Fluid Transfer Drugs Devices Market Status by Category

    • 3.1 IV Fluid Transfer Drugs Devices Category Introduction
      • 3.1.1 Infusion Bags
      • 3.1.2 Infusion Devices
      • 3.1.3 Others
    • 3.2 Global IV Fluid Transfer Drugs Devices Market by Category
      • 3.2.1 Global IV Fluid Transfer Drugs Devices Sales Volume by Category (2016-2021)
      • 3.2.2 Global IV Fluid Transfer Drugs Devices Sales Value by Category (2016-2021)
      • 3.2.3 Global IV Fluid Transfer Drugs Devices Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional IV Fluid Transfer Drugs Devices Market Status by End User/Segment

    • 4.1 IV Fluid Transfer Drugs Devices Segment by End User/Segment
      • 4.1.1 Hospitals
      • 4.1.2 Clinics
      • 4.1.3 Others
    • 4.2 Global IV Fluid Transfer Drugs Devices Market by End User/Segment
      • 4.2.1 Global IV Fluid Transfer Drugs Devices Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global IV Fluid Transfer Drugs Devices Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global IV Fluid Transfer Drugs Devices Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global IV Fluid Transfer Drugs Devices Market Status by Region

    • 5.1 Global IV Fluid Transfer Drugs Devices Market by Region
      • 5.1.1 Global IV Fluid Transfer Drugs Devices Sales Volume by Region
      • 5.1.2 Global IV Fluid Transfer Drugs Devices Sales Value by Region
    • 5.2 North America IV Fluid Transfer Drugs Devices Market Status
    • 5.3 Europe IV Fluid Transfer Drugs Devices Market Status
    • 5.4 Asia Pacific IV Fluid Transfer Drugs Devices Market Status
    • 5.5 Central & South America IV Fluid Transfer Drugs Devices Market Status
    • 5.6 Middle East & Africa IV Fluid Transfer Drugs Devices Market Status

    6 North America IV Fluid Transfer Drugs Devices Market Status

    • 6.1 North America IV Fluid Transfer Drugs Devices Market by Country
      • 6.1.1 North America IV Fluid Transfer Drugs Devices Sales Volume by Country (2016-2021)
      • 6.1.2 North America IV Fluid Transfer Drugs Devices Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe IV Fluid Transfer Drugs Devices Market Status

    • 7.1 Europe IV Fluid Transfer Drugs Devices Market by Country
      • 7.1.1 Europe IV Fluid Transfer Drugs Devices Sales Volume by Country (2016-2021)
      • 7.1.2 Europe IV Fluid Transfer Drugs Devices Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific IV Fluid Transfer Drugs Devices Market Status

    • 8.1 Asia Pacific IV Fluid Transfer Drugs Devices Market by Country
      • 8.1.1 Asia Pacific IV Fluid Transfer Drugs Devices Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific IV Fluid Transfer Drugs Devices Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America IV Fluid Transfer Drugs Devices Market Status

    • 9.1 Central & South America IV Fluid Transfer Drugs Devices Market by Country
      • 9.1.1 Central & South America IV Fluid Transfer Drugs Devices Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America IV Fluid Transfer Drugs Devices Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa IV Fluid Transfer Drugs Devices Market Status

    • 10.1 Middle East & Africa IV Fluid Transfer Drugs Devices Market by Country
      • 10.1.1 Middle East & Africa IV Fluid Transfer Drugs Devices Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa IV Fluid Transfer Drugs Devices Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 IV Fluid Transfer Drugs Devices Manufacturing Cost Analysis
    • 11.5 IV Fluid Transfer Drugs Devices Sales Channel and Distributors Analysis
      • 11.5.1 IV Fluid Transfer Drugs Devices Sales Channel
      • 11.5.2 IV Fluid Transfer Drugs Devices Distributors
    • 11.6 IV Fluid Transfer Drugs Devices Downstream Major Buyers

    12 Global IV Fluid Transfer Drugs Devices Market Forecast by Category and by End User/Segment

    • 12.1 Global IV Fluid Transfer Drugs Devices Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global IV Fluid Transfer Drugs Devices Forecast by Category
      • 12.2.1 Global IV Fluid Transfer Drugs Devices Sales Volume Forecast by Category
      • 12.2.2 Global IV Fluid Transfer Drugs Devices Sales Value Forecast by Category
      • 12.2.3 Global IV Fluid Transfer Drugs Devices Price Forecast by Category
    • 12.3 Global IV Fluid Transfer Drugs Devices Forecast by End User/Segment
      • 12.3.1 Global IV Fluid Transfer Drugs Devices Sales Volume Forecast by End User/Segment
      • 12.3.2 Global IV Fluid Transfer Drugs Devices Sales Value Forecast by End User/Segment
      • 12.3.3 Global IV Fluid Transfer Drugs Devices Price Forecast by End User/Segment

    13 Global IV Fluid Transfer Drugs Devices Market Forecast by Region/Country

    • 13.1 Global IV Fluid Transfer Drugs Devices Market Forecast by Region (2022-2027)
      • 13.1.1 Global IV Fluid Transfer Drugs Devices Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global IV Fluid Transfer Drugs Devices Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Ypsomed Holding AG
      • 14.1.1 Company Information
      • 14.1.2 IV Fluid Transfer Drugs Devices Product Introduction
      • 14.1.3 Ypsomed Holding AG IV Fluid Transfer Drugs Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Unilife Corporation
      • 14.2.1 Company Information
      • 14.2.2 IV Fluid Transfer Drugs Devices Product Introduction
      • 14.2.3 Unilife Corporation IV Fluid Transfer Drugs Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Sanofi
      • 14.3.1 Company Information
      • 14.3.2 IV Fluid Transfer Drugs Devices Product Introduction
      • 14.3.3 Sanofi IV Fluid Transfer Drugs Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Pfizer
      • 14.4.1 Company Information
      • 14.4.2 IV Fluid Transfer Drugs Devices Product Introduction
      • 14.4.3 Pfizer IV Fluid Transfer Drugs Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Owen Mumford
      • 14.5.1 Company Information
      • 14.5.2 IV Fluid Transfer Drugs Devices Product Introduction
      • 14.5.3 Owen Mumford IV Fluid Transfer Drugs Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Novartis International AG
      • 14.6.1 Company Information
      • 14.6.2 IV Fluid Transfer Drugs Devices Product Introduction
      • 14.6.3 Novartis International AG IV Fluid Transfer Drugs Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Emergent BioSolutions
      • 14.7.1 Company Information
      • 14.7.2 IV Fluid Transfer Drugs Devices Product Introduction
      • 14.7.3 Emergent BioSolutions IV Fluid Transfer Drugs Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Emerade
      • 14.8.1 Company Information
      • 14.8.2 IV Fluid Transfer Drugs Devices Product Introduction
      • 14.8.3 Emerade IV Fluid Transfer Drugs Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 Biogen Idec, Inc
      • 14.9.1 Company Information
      • 14.9.2 IV Fluid Transfer Drugs Devices Product Introduction
      • 14.9.3 Biogen Idec, Inc IV Fluid Transfer Drugs Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 SWOT Analysis
    • 14.10 Bayer AG
      • 14.10.1 Company Information
      • 14.10.2 IV Fluid Transfer Drugs Devices Product Introduction
      • 14.10.3 Bayer AG IV Fluid Transfer Drugs Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.10.4 SWOT Analysis
    • 14.11 Amedra Pharmaceuticals
    • 14.12 ALK Abello

    15 Conclusion

      16 Methodology

      Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global IV Fluid Transfer Drugs Devices market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global IV Fluid Transfer Drugs Devices market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

      Segmented by Category
      Infusion Bags
      Infusion Devices
      Others

      Segmented by End User/Segment
      Hospitals
      Clinics
      Others

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Ypsomed Holding AG
      Unilife Corporation
      Sanofi
      Pfizer
      Owen Mumford
      Novartis International AG
      Emergent BioSolutions
      Emerade
      Biogen Idec, Inc
      Bayer AG
      Amedra Pharmaceuticals
      ALK Abello
      Buy now